Actively Recruiting
Evaluation of Brain Blood Flow and Lung Function Using Near Infrared Spectroscopy in Survivors of Hodgkin Lymphoma Treated with Chest Radiation and Bleomycin
Led by St. Jude Children's Research Hospital · Updated on 2026-09-01
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults who survived Hodgkin Lymphoma HL treated with chest radiation and bleomycin to understand how these treatments affect brain function and cardiopulmonary health over time. This observational study compares HL survivors to non-cancer controls matched by age, sex, race, and ethnicity, aiming to explore the connection between long-term treatment effects and brain blood flow and oxygenation. Participants include HL survivors treated at St. Jude Childrens Research Hospital and community controls such as relatives, friends, or employees of the hospital. The study uses a wearable, non-invasive device called Near Infrared Spectroscopy NIRS to measure brain blood flow during physical activity. Researchers also assess lung function and gas exchange during rest and exercise to compare the two groups. During the study, participants undergo brain imaging with NIRS, cardiopulmonary exercise testing, pulmonary function tests, and neurocognitive assessments at baseline. These evaluations help measure dynamic changes in cerebral blood flow and oxygenation as well as lung capacity and brain function. The study involves initial testing visits and monitoring the participants health over time without active treatment. Participation duration varies but includes follow-up through 2027.
CONDITIONS
Brief Title
Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Research Team
N
Nicholas Phillips, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here